Cargando…

Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition

BACKGROUND: Lipocalin2 (LCN2) is a secretory protein that is aberrantly expressed in several types of cancer and has been involved in metastatic progression. However, neither mechanisms nor the role that LCN2 plays in the metastasis of colorectal cancer are clear. METHODS: LCN2 expression in colorec...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Meibao, Feng, Jieqiong, Chen, Wuzhen, Wang, Wubin, Wu, Xuesong, Zhang, Jing, Xu, Fangying, Lai, Maode
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135816/
https://www.ncbi.nlm.nih.gov/pubmed/27912767
http://dx.doi.org/10.1186/s12943-016-0564-9
_version_ 1782471614396366848
author Feng, Meibao
Feng, Jieqiong
Chen, Wuzhen
Wang, Wubin
Wu, Xuesong
Zhang, Jing
Xu, Fangying
Lai, Maode
author_facet Feng, Meibao
Feng, Jieqiong
Chen, Wuzhen
Wang, Wubin
Wu, Xuesong
Zhang, Jing
Xu, Fangying
Lai, Maode
author_sort Feng, Meibao
collection PubMed
description BACKGROUND: Lipocalin2 (LCN2) is a secretory protein that is aberrantly expressed in several types of cancer and has been involved in metastatic progression. However, neither mechanisms nor the role that LCN2 plays in the metastasis of colorectal cancer are clear. METHODS: LCN2 expression in colorectal cancer was detected by immunohistochemistry in 400 tissue specimens and Kaplan-Meier survival analysis was performed. In vitro, real-time PCR, western blot, colony formation assay, immunofluorescence assay, wound healing assay, migration and invasion experiment were performed to investigate the effects of LCN2 in epithelial mesenchymal transition (EMT), migration and invasion, respectively. In vivo mouse xenograft and metastasis models were utilized to determine tumorigenicity and metastasis ability, and immunohistochemistry, real-time PCR, western blot were used to evaluate the related protein expression. Luciferase reporter assay was used to explore the role of LCN2 on NF-ĸB promoter. RESULTS: LCN2 was highly expressed in 66.5% of the specimens, and significantly correlated with positive E-cadherin in the membrane and negative nuclear β-catenin. Higher expression of LCN2 together with negative NF-κB expression was negatively related to nuclear accumulation of snail and predicted favorable prognosis. LCN2 blocked cell proliferation, migration and invasion in vitro and in vivo, and inhibited translocation of NF-κB into nucleus. NF-κB could reverse the effect of LCN2 on EMT and promote snail expression. Rescued snail expression had similar effect without influencing NF-κB activity. CONCLUSION: LCN2 may be an important negative regulator in EMT, invasion and metastasis of CRC via acting as upstream of NF-κB/snail signaling pathway. Thereby combinative manipulation of LCN2 and NF-κB/snail pathway may represent a novel and promising therapeutic approach for the patients with CRC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-016-0564-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5135816
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51358162016-12-15 Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition Feng, Meibao Feng, Jieqiong Chen, Wuzhen Wang, Wubin Wu, Xuesong Zhang, Jing Xu, Fangying Lai, Maode Mol Cancer Research BACKGROUND: Lipocalin2 (LCN2) is a secretory protein that is aberrantly expressed in several types of cancer and has been involved in metastatic progression. However, neither mechanisms nor the role that LCN2 plays in the metastasis of colorectal cancer are clear. METHODS: LCN2 expression in colorectal cancer was detected by immunohistochemistry in 400 tissue specimens and Kaplan-Meier survival analysis was performed. In vitro, real-time PCR, western blot, colony formation assay, immunofluorescence assay, wound healing assay, migration and invasion experiment were performed to investigate the effects of LCN2 in epithelial mesenchymal transition (EMT), migration and invasion, respectively. In vivo mouse xenograft and metastasis models were utilized to determine tumorigenicity and metastasis ability, and immunohistochemistry, real-time PCR, western blot were used to evaluate the related protein expression. Luciferase reporter assay was used to explore the role of LCN2 on NF-ĸB promoter. RESULTS: LCN2 was highly expressed in 66.5% of the specimens, and significantly correlated with positive E-cadherin in the membrane and negative nuclear β-catenin. Higher expression of LCN2 together with negative NF-κB expression was negatively related to nuclear accumulation of snail and predicted favorable prognosis. LCN2 blocked cell proliferation, migration and invasion in vitro and in vivo, and inhibited translocation of NF-κB into nucleus. NF-κB could reverse the effect of LCN2 on EMT and promote snail expression. Rescued snail expression had similar effect without influencing NF-κB activity. CONCLUSION: LCN2 may be an important negative regulator in EMT, invasion and metastasis of CRC via acting as upstream of NF-κB/snail signaling pathway. Thereby combinative manipulation of LCN2 and NF-κB/snail pathway may represent a novel and promising therapeutic approach for the patients with CRC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-016-0564-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-12-03 /pmc/articles/PMC5135816/ /pubmed/27912767 http://dx.doi.org/10.1186/s12943-016-0564-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Feng, Meibao
Feng, Jieqiong
Chen, Wuzhen
Wang, Wubin
Wu, Xuesong
Zhang, Jing
Xu, Fangying
Lai, Maode
Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition
title Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition
title_full Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition
title_fullStr Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition
title_full_unstemmed Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition
title_short Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition
title_sort lipocalin2 suppresses metastasis of colorectal cancer by attenuating nf-κb-dependent activation of snail and epithelial mesenchymal transition
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135816/
https://www.ncbi.nlm.nih.gov/pubmed/27912767
http://dx.doi.org/10.1186/s12943-016-0564-9
work_keys_str_mv AT fengmeibao lipocalin2suppressesmetastasisofcolorectalcancerbyattenuatingnfkbdependentactivationofsnailandepithelialmesenchymaltransition
AT fengjieqiong lipocalin2suppressesmetastasisofcolorectalcancerbyattenuatingnfkbdependentactivationofsnailandepithelialmesenchymaltransition
AT chenwuzhen lipocalin2suppressesmetastasisofcolorectalcancerbyattenuatingnfkbdependentactivationofsnailandepithelialmesenchymaltransition
AT wangwubin lipocalin2suppressesmetastasisofcolorectalcancerbyattenuatingnfkbdependentactivationofsnailandepithelialmesenchymaltransition
AT wuxuesong lipocalin2suppressesmetastasisofcolorectalcancerbyattenuatingnfkbdependentactivationofsnailandepithelialmesenchymaltransition
AT zhangjing lipocalin2suppressesmetastasisofcolorectalcancerbyattenuatingnfkbdependentactivationofsnailandepithelialmesenchymaltransition
AT xufangying lipocalin2suppressesmetastasisofcolorectalcancerbyattenuatingnfkbdependentactivationofsnailandepithelialmesenchymaltransition
AT laimaode lipocalin2suppressesmetastasisofcolorectalcancerbyattenuatingnfkbdependentactivationofsnailandepithelialmesenchymaltransition